MedPath

Glycaemic Response and Insulinaemic Response for Nutralys S85 Plus and Whey Protein

Not Applicable
Completed
Conditions
Healthy
Interventions
Dietary Supplement: 50 g Glucose
Dietary Supplement: 20 g NUTRALYS®S85 Plus pea protein
Dietary Supplement: 10 g Whey protein concentrate
Dietary Supplement: 20 g Whey protein concentrate
Dietary Supplement: 10 g NUTRALYS®S85 Plus pea protein
Registration Number
NCT04871971
Lead Sponsor
Oxford Brookes University
Brief Summary

A comparison of the glycaemic response and insulinaemic response to glucose, Nutralys S85 Plus pea protein and whey protein using a single-blind, randomised, repeat measure, crossover design trial.

Detailed Description

A single-blind, randomised, repeat measure, crossover design trial will be used to study the glycaemic response and insulinaemic response following consumption of five products: one reference product (50 g available carbohydrate Glucose) and four test products (50 g available carbohydrate Glucose with 10 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate Glucose with 20 g NUTRALYS®S85 Plus pea protein, 50 g available carbohydrate Glucose with 10 g Whey protein concentrate and 50 g available carbohydrate Glucose with 20 g Whey protein concentrate).

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Aged 18 to 60 years
  • Body mass index (BMI) less than 30kg/m2
Exclusion Criteria
  • Pregnant or lactating
  • Fasting blood glucose value > 6.1 mmol/l
  • Any known food allergy or intolerance
  • Medical condition(s) or medication(s) known to affect glucose regulation or appetite and/or which influence digestion and absorption of nutrients
  • Known history of diabetes mellitus or the use of antihyperglycaemic drugs or insulin to treat diabetes and related conditions
  • Major medical or surgical event requiring hospitalization within the preceding 3 months
  • Use of steroids, protease inhibitors or antipsychotics (all of which have major effects on glucose metabolism and body fat distribution)
  • Unable to comply with experimental procedures or did not follow GR testing safety guidelines.

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Glucose50 g GlucoseGlucose 50 g available carbohydrate
20 g NUTRALYS®S85 Plus pea protein20 g NUTRALYS®S85 Plus pea protein50 g available carbohydrate Glucose + 20 g NUTRALYS®S85 Plus pea protein
10 g Whey protein concentrate10 g Whey protein concentrate50 g available carbohydrate Glucose + 10 g Whey protein concentrate
20 g Whey protein concentrate20 g Whey protein concentrate50 g available carbohydrate Glucose + 20 g Whey protein concentrate
10 g NUTRALYS®S85 Plus pea protein10 g NUTRALYS®S85 Plus pea protein50 g available carbohydrate Glucose + 10 g NUTRALYS®S85 Plus pea protein
Primary Outcome Measures
NameTimeMethod
Area under the blood glucose concentration versus time curve3 hours

Area under the blood glucose concentration versus time curve was calculated by trapezoidal rule

Area under the plasma insulin concentration versus time curve3 hours

Area under the plasma insulin concentration versus time curve was calculated by trapezoidal rule

Change in plasma insulin response from baseline for 3 hours3 hours

Change in postprandial plasma insulin response from baseline was measured at 15 min, 30 min, 45 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours

Time of plasma insulin peak (Tmax)0-3 hours

Time of plasma insulin peak after consumption of the test food

Change in blood glucose response from baseline for 3 hours3 hours

Change in postprandial blood glucose response from baseline was measured at 15 min, 30 min, 45 min, 1 hour, 1.5 hours, 2 hours, 2.5 hours and 3 hours

Peak plasma insulin concentration (Cmax)0-3 hours

Peak plasma insulin concentration (Cmax) after consumption of the test food

Time of blood glucose peak (Tmax)0-3 hours

Time of blood glucose peak after consumption of the test food

Peak blood glucose concentration (Cmax)0-3 hours

Peak blood glucose concentration (Cmax) after consumption of the test food

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Oxford Brookes Centre for Nutrition and Health

🇬🇧

Oxford, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath